cytarabine and Peripheral Nervous System Diseases

cytarabine has been researched along with Peripheral Nervous System Diseases in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19907 (29.17)18.7374
1990's8 (33.33)18.2507
2000's6 (25.00)29.6817
2010's2 (8.33)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Jabbour, EJ; Kadia, TM; Kantarjian, HM; Rausch, CR1
Abe, A; Hayasaka, K; Kawakami, K; Kawano, Y; Kumamoto, T; Nishikawa, T; Okamoto, Y; Tonooka, S1
Altman, JK; Andreeff, M; Borthakur, G; Brandwein, J; Carter, BZ; Estey, EH; Hedley, DW; Jacob, C; Jolivet, J; Karp, JE; Kassis, J; LaCasse, E; Mak, DH; Morris, SJ; Schiller, GJ; Schimmer, AD; Tallman, MS; Xu, W1
Almohamad, W; Brahimi, N; Delmas-Marsalet, B; Frénoy, N; Goldschmidt, E; Guettier, C; Gumus, Y; Haydar, M; Innominato, P; Machover, D; Misra, SC; Saffroy, R; Ulusakarya, A1
Buffardi, S; Cianciulli, E; Mangione, A; Marchese, L; Menna, G; Misuraca, A; Nastro, A; Parasole, R; Petruzziello, F; Poggi, V1
Holyoake, TL; McQuaker, IG; Osborne, WL; Parker, AN1
Choudhry, VP; Dixit, A; Kannan, M; Mahapatra, M; Saxena, R1
Asai, O; Dobashi, N; Minami, J; Ogasawara, Y; Osawa, H; Saito, T; Takahara, S; Takei, Y; Usui, N; Yamaguchi, Y; Yano, S1
Anand, P; Anand, U; Birch, R; Bountra, C; Chessell, I; Otto, WR; Sinisi, M1
Koskela, K; Pelliniemi, TT; Remes, K1
Estey, E; Gandhi, V; Kantarjian, H; Keating, MJ; Plunkett, W; Rios, MB1
Adde, MA; Arndt, C; Gootenberg, J; Horak, ID; Magrath, IT; Neely, JE; Nieder, ML; Seibel, NL; Shad, AT; Venzon, DJ; Weintraub, M1
Forman, SJ; Hinton, DR; Openshaw, H; Slatkin, NE; Stein, AS1
Openshaw, H1
Mitchell, DC; Win, N1
Baker, WJ; Royer, GL; Weiss, RB1
Bonnet, D; Ell, J; Gibson, J; Joshua, D; Paul, M; Pollard, J; Rahme, N1
Benstead, TJ; Hayne, OA; McCormick, CW; Nevill, TJ1
Degos, JD; Malapert, D1
Filling-Katz, MR; Scherokman, B; Tell, D1
Capizzi, RL; Cooper, MR; Lyerly, ES; Powell, BL1
Borgeat, A; De Muralt, B; Stalder, M1
Cousar, JB; Greco, FA; Greer, JP; Hainsworth, JD; Stein, RS; Wolff, SN1
Powles, RL; Russell, JA1

Reviews

3 review(s) available for cytarabine and Peripheral Nervous System Diseases

ArticleYear
Peripheral neuropathy after bone marrow transplantation.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 1997, Volume: 3, Issue:4

    Topics: Bone Marrow Transplantation; Cyclosporine; Cytarabine; Demyelinating Diseases; Humans; Immunosuppressive Agents; Interferon-alpha; Peripheral Nervous System Diseases; Tacrolimus; Time Factors

1997
Cytarabine and neurologic toxicity.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:4

    Topics: Central Nervous System Diseases; Cytarabine; Humans; Peripheral Nervous System Diseases

1991
[Painful legs and moving toes. Neuropathy caused by cytarabine].
    Revue neurologique, 1989, Volume: 145, Issue:12

    Topics: Adolescent; Axons; Carbamazepine; Cytarabine; Dose-Response Relationship, Drug; Humans; Leg; Male; Movement Disorders; Pain; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reflex, Abnormal; Sensory Receptor Cells; Syndrome; Toes

1989

Trials

4 trial(s) available for cytarabine and Peripheral Nervous System Diseases

ArticleYear
Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Oct-01, Volume: 27, Issue:28

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Oligonucleotides; Peripheral Nervous System Diseases; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Treatment Outcome; X-Linked Inhibitor of Apoptosis Protein

2009
Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2010, Volume: 64, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Dexamethasone; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Neoplasm Recurrence, Local; Organoplatinum Compounds; Peripheral Nervous System Diseases; Rituximab; Treatment Outcome

2010
Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:4-5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Colitis; Combined Modality Therapy; Conjunctivitis; Cytarabine; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Pancreatitis; Peripheral Nervous System Diseases; Remission Induction; Salvage Therapy; Treatment Outcome; Vidarabine

1993
Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Foot Diseases; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Infant; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Pain; Peripheral Nervous System Diseases; Vincristine

1996

Other Studies

17 other study(ies) available for cytarabine and Peripheral Nervous System Diseases

ArticleYear
Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
    Cancer, 2020, 03-15, Volume: 126, Issue:6

    Topics: Age Factors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Constipation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Monitoring; Fusion Proteins, bcr-abl; Genetic Predisposition to Disease; Humans; Injections, Spinal; Intercellular Signaling Peptides and Proteins; Kidney; Methotrexate; Ophthalmic Solutions; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Protein-Tyrosine Kinases; Vincristine

2020
Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:7

    Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Charcot-Marie-Tooth Disease; Contraindications; Cytarabine; Daunorubicin; Etoposide; Gait Disorders, Neurologic; Humans; Male; Mercaptopurine; Methotrexate; Muscle Weakness; Neural Conduction; Peripheral Nervous System Diseases; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Vincristine

2008
Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Central Nervous System; Central Nervous System Diseases; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Electroencephalography; Female; Humans; Infant; Leukemic Infiltration; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retrospective Studies; Tomography, X-Ray Computed; Vincristine

2010
Fatal peripheral neuropathy following FLA chemotherapy.
    Clinical and laboratory haematology, 2004, Volume: 26, Issue:4

    Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Interactions; Fatal Outcome; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Middle Aged; Peripheral Nervous System Diseases; Pyrimidines; Triazoles; Vidarabine; Voriconazole

2004
Roles of protein C, protein S, and antithrombin III in acute leukemia.
    American journal of hematology, 2006, Volume: 81, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Asparaginase; Cyclophosphamide; Cytarabine; Disseminated Intravascular Coagulation; Female; Humans; Leukemia, Myeloid, Acute; Male; Mercaptopurine; Methotrexate; Myocardial Infarction; Peripheral Nervous System Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prednisone; Protein C; Protein S; Thrombosis; Vincristine

2006
Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2006, Volume: 12, Issue:3

    Topics: Acute Disease; Cytarabine; Humans; Leukemia, Myeloid; Male; Middle Aged; Peripheral Nervous System Diseases

2006
Cytosine arabinoside affects the heat and capsaicin receptor TRPV1 localisation and sensitivity in human sensory neurons.
    Journal of neuro-oncology, 2008, Volume: 89, Issue:1

    Topics: Adult; Antimetabolites, Antineoplastic; Calcium; Capsaicin; Cell Division; Cell Membrane; Cell Survival; Cells, Cultured; Cytarabine; Dose-Response Relationship, Drug; Ganglia, Spinal; GAP-43 Protein; Humans; Ionomycin; Neurons, Afferent; Peripheral Nervous System Diseases; Sensory System Agents; Time Factors; TRPV Cation Channels

2008
VAD regimen in the treatment of resistant multiple myeloma: slow or fast infusion?
    Leukemia & lymphoma, 1993, Volume: 10, Issue:4-5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dexamethasone; Female; Humans; Life Tables; Male; Middle Aged; Multiple Myeloma; Neutropenia; Peripheral Nervous System Diseases; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine

1993
Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.
    Cancer, 1996, Nov-01, Volume: 78, Issue:9

    Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cytarabine; Demyelinating Diseases; Female; Humans; Leukemia; Male; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies

1996
Patchy polyneuropathy in acute promyelocytic leukaemia.
    Clinical and laboratory haematology, 1992, Volume: 14, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Paraneoplastic Syndromes; Peripheral Nervous System Diseases; Remission Induction; Translocation, Genetic; Transplantation, Homologous

1992
Fatal peripheral neuropathy associated with axonal degeneration after high-dose cytosine arabinoside in acute leukaemia.
    British journal of haematology, 1991, Volume: 79, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axons; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male; Peripheral Nervous System Diseases; Sural Nerve

1991
Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside.
    American journal of hematology, 1989, Volume: 32, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Demyelinating Diseases; Horner Syndrome; Humans; Leukemia, Promyelocytic, Acute; Male; Peripheral Nervous System Diseases

1989
Brachial plexus neuropathy following high-dose cytarabine in acute monoblastic leukemia.
    Cancer treatment reports, 1985, Volume: 69, Issue:9

    Topics: Arm; Brachial Plexus; Cytarabine; Humans; Leukemia, Monocytic, Acute; Male; Middle Aged; Muscles; Nervous System Neoplasms; Neurologic Examination; Pain; Peripheral Nervous System Diseases; Recurrence; Time Factors

1985
Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:1

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Nervous System Diseases

1986
Peripheral neuropathy associated with high-dose Ara-C therapy.
    Cancer, 1986, Aug-15, Volume: 58, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Axons; Cytarabine; Electromyography; Electrophysiology; Female; Humans; Leg; Leukemia, Lymphoid; Muscles; Neurologic Examination; Peripheral Nervous System Diseases; Wallerian Degeneration

1986
Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosi
    Cancer treatment reports, 1986, Volume: 70, Issue:8

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Neoplasm Staging; Neutropenia; Peripheral Nervous System Diseases; Prednisone; Prognosis; Thrombocytopenia; Vincristine

1986
Letter: neuropathy due to cytosine arabinoside.
    British medical journal, 1974, Dec-14, Volume: 4, Issue:5945

    Topics: Cytarabine; Foot; Hand; Humans; Injections, Intravenous; Leukemia, Myeloid; Male; Middle Aged; Peripheral Nervous System Diseases

1974